Stocks TelegraphStocks Telegraph
Stock Ideas

DAWN Stock Forecast and Stock Price Prediction

NASDAQ : DAWN

Day One Biopharmaceuticals

$21.53
00
Open: 9:30 AM
59.72
BESG ScoreESG Rating

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$21.530%Since 2 Weeks
Predicted Price$24.1712.27%For 2 Weeks
Upper Predicted Price$27.5427.92%For 2 Weeks
Lower Predicted Price$20.55-4.55%For 2 Weeks

Forecast Score Based on 2 Weeks

020406080100
56

Based on our forecast, the price of DAWN will rise by +12.27% over the next 2 Weeks and hit $24.17 by Wednesday, May 6, 2026. In that time frame, DAWN's share price is expected to range between $20.55 and $27.54.

BearishAverageBullish
DatePredicted LowerPredictedPredicted Upper
May 6, 202622.0726.0729.55
May 5, 202621.2224.8128.32
May 4, 202621.0924.8728.47
May 1, 202621.3824.8728.41
Apr 30, 202620.4924.1627.72
Apr 29, 202621.5925.1928.92
Apr 28, 202620.2023.9327.57
Apr 27, 202620.3623.9927.56
Apr 24, 202620.3923.9927.71
Apr 23, 202619.8623.2827.05

DAWN shares remained flat 0 in Friday, April 24, 2026's trading session, starting and closing at a previous close of $21.53 to move at $21.53. The stock demonstrated notable intraday movement (see DAWN's key stats for a full breakdown), fluctuating between $21.53 and $21.53, a 0 trading range. While recent weeks have seen some volatility, DAWN has managed to secure a +0.42% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 2.97M shares changing hands, 889.52K more than the previous session. This amounted to $64.02M in total market activity.

Will DAWN Continue Its Upward Trend?

According to analyst ratings and projections for DAWN, Day One Biopharmaceuticals, Inc. shares are anticipated to increase by +27.13%, potentially reaching $29.55 per share by May 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for DAWN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the DAWN stock forecast, now is a good time to buy DAWN stock because its current trading price is -17.42% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on DAWN covering social and institutional perspectives.

DAWN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into DAWN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 77.69% to 81.30%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 70.08%, indicates significant medium-term strength. However, the 100-day RSI, at 64.24%, points to growing bullish momentum over the long term. Insights into DAWN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Day One Biopharmaceuticals, Inc. Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Day One Biopharmaceuticals, Inc. (DAWN) is positioned to show a strong performance in April 2026. The price is predicted to move between $7.45 and $10.33, settling at an average of $8.83. This could translate to a -58.99% loss.

May 2026

Based on current market signals, Day One Biopharmaceuticals, Inc. is projected to trend may 2026. We forecast a trading range from $7.19 to $11.36, with a likely average price of $9.20. Investors could expect a potential return of -57.27%.

June 2026

Our predictive algorithms indicate Day One Biopharmaceuticals, Inc. stock may see a shift in June 2026. The expected range spans $7.88$11.16, with an average target of $9.46. This represents a cautious outlook and a possible loss of -56.06%.

July 2026

Analyzing established trends, Day One Biopharmaceuticals, Inc. looks set to move in July 2026. Projections place the stock between $7.15 and $10.86, averaging around $8.86. This suggests a -58.85% loss from current levels.

August 2026

Market indicators suggest Day One Biopharmaceuticals, Inc. could experience notable changes during August 2026. Prices could fluctuate within $7.86 to $11.71, with a midpoint forecast of $9.78. The stock might deliver a -54.58% loss.

September 2026

Forecasting for September 2026, models estimate that Day One Biopharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $6.76 and $11.25, averaging $9.17. This signals a cautious trajectory with potential returns around -57.41%.

October 2026

According to our latest forecast models, Day One Biopharmaceuticals, Inc. (DAWN) is positioned to show a strong performance in October 2026. The price is predicted to move between $5.52 and $10.69, settling at an average of $8.47. This could translate to a -60.66% loss.

November 2026

Based on current market signals, Day One Biopharmaceuticals, Inc. is projected to trend november 2026. We forecast a trading range from $7.22 to $11.79, with a likely average price of $8.90. Investors could expect a potential return of -58.66%.

December 2026

Our predictive algorithms indicate Day One Biopharmaceuticals, Inc. stock may see a shift in December 2026. The expected range spans $6.43$10.03, with an average target of $8.17. This represents a cautious outlook and a possible loss of -62.05%.

January 2027

Analyzing established trends, Day One Biopharmaceuticals, Inc. looks set to move in January 2027. Projections place the stock between $7.21 and $11.01, averaging around $9.10. This suggests a -57.73% loss from current levels.

February 2027

Market indicators suggest Day One Biopharmaceuticals, Inc. could experience notable changes during February 2027. Prices could fluctuate within $5.94 to $10.88, with a midpoint forecast of $8.48. The stock might deliver a -60.61% loss.

March 2027

Forecasting for March 2027, models estimate that Day One Biopharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $5.88 and $9.83, averaging $7.87. This signals a cautious trajectory with potential returns around -63.45%.

April 2027

According to our latest forecast models, Day One Biopharmaceuticals, Inc. (DAWN) is positioned to show a strong performance in April 2027. The price is predicted to move between $6.57 and $9.68, settling at an average of $8.14. This could translate to a -62.19% loss.

DAWN's history of dividends and stock splits also plays a role in long-term investor confidence.

Frequently Asked Questions

What is the DAWN stock price prediction for next 2 weeks?
According to our price prediction algorithm,Day One Biopharmaceuticals, Inc. (DAWN) price will be around $24.17 in the next 2 weeks. This means it will increase by +12.27% from the last closing price. This prediction may vary from other time period filters for DAWN stock.
What can be the highest Possible price of DAWN stock in next 2 weeks?
Our forecast algorithm expects that in 2 weeks, DAWN can achieve the highest price of $27.54 which is +27.92% higher than last closing price. This prediction may vary from other time period filters for DAWN stock.
What can be the lowest Possible price of DAWN stock in next 2 weeks?
As per the forecast and algorithmic analysis, DAWN stock price can be as low as $20.55 which is -4.55% lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for DAWN stock.
Will DAWN stock go high in the next 2 weeks?
Yes, our stock forecasting algorithm shows that DAWN stock will gain+12.27% in the next 2 weeks. This prediction may vary from other time period filters for DAWN stock.
What is DAWN stock last closing price?
Last closing price of DAWN stock was $21.53.
What is DAWN stock price prediction?
DAWN stock price prediction means predicting the future closing prices of DAWN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of DAWN stock in a certain time period.
How we predict DAWN stock future prices?
If you are searching for DAWN stock forecast, analysis or price prediction, then you might be wondering what Day One Biopharmaceuticals, Inc. (DAWN) will do in the future. Our DAWN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This DAWN price prediction will likely answer most of your questions.
How frequent we update DAWN stock predictions?
We are updating the forecasts for the DAWN stock on daily basis.
Is using ML forecasting for DAWN stock a good way?
Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.
Is the Prediction for DAWN stock same for all the time periods?
No, the prediction for DAWN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph